Idiosyncratic Drug–induced Neutropenia Secondary to Ofatumumab Exposure in Multiple Sclerosis: A Case Report and Analysis of Food and Drug Administration Adverse Event Reporting System (P8-1.012)
To highlight idiosyncratic drug-induced neutropenia (IDIN) as a complication of ofatumumab exposure in multiple sclerosis (MS).
Authors
- Michelle Maynard
- Sam Hooshmand (ORCID: https://orcid.org/0000-0002-6682-1923)
- R Viswanathan
- Uzoma Wamuo
Institutions
- Medical College of Wisconsin (US)
- Indiana University School of Medicine
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211410
- Citations
- 1
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 1.05